3D Bioprinting: Can India capitalise on a growing trend?

01-08-2023

Kavita Arora and Shaivya Dhavan

3D Bioprinting: Can India capitalise on a growing trend?

Scharfsinn / Shutterstock.com

Amid worldwide interest, India could position itself as a global hub for a desperately needed technology, say Kavita Arora and Shaivya Dhawan of K&S Partners.

The shortage of organ donors and the resulting loss of lives due to tissue damage or organ failure is a global crisis. In India, approximately 500,000 people die annually due to the lack of an organ donor.

In the US, over 104,000 people were on the national transplant waiting list as of June 2023. Regenerative medicine and tissue engineering is a promising breakthrough with the potential to save lives, and perhaps revolutionise the healthcare and pharmaceutical industries.

3D bioprinting: A new frontier


India, bioprinting, 3d printing, additive manufacturing, organ transplants, tissue engineering, ex vivo liver regeneration

LSIPR